Citations

Showing 10 of 108152 citations.

Continuous Improvement of Blood Redraw Rates in the Emergency Department: A 5-Year Journey
Block, Darci R , Griesmann, Laurie D, Rickard, Twyla M, Backus, Linda, Finley, Janet L., Goyal, Deepi G. , Karon, Brad S. , Rickard, Twyla, Finley, Janet, Goyal, Deepi

Mayo Clinic

The Journal of Applied Laboratory Medicine | August 2, 2019 | Volume: 4 | Issue: 2 | Pages: 284-286

10.1373/jalm.2019.029934 | PMID 31639677 Get It

How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery)
Pauwels, Ans, Andrews, Christopher N. , Attwood, Stephen , Berrisford, Richard, Bisschops, Raf , Boeckxstaens, Guy E. , Bor, Serhat , Bredenoord, Albert J. , Cicala, Michele , Corsetti, Maura , Fornari, Fernando , Gyawali, C. Prakash , Hatlebakk, Jan, Johnson, Scott, Lerut, Toni, Lundell, Lars, Mattioli, Sandro , Omari, Taher , Pandolfino, John E. , Penagini, Roberto , Rice, Thomas W., Roelandt, Philip , Rommel, Nathalie , Savarino, Vincenzo , Vanuytsel, Tim , Vela, Marcelo F. , Watson, David I. , Tack, Jan , Lerut, Antoon , Tack, Jan , Gyawali, C P , Corsetti, M , Penagini, Roberto , Bisschops, Raf , Bor, Serhat , Omari, Taher , Boeckxstaens, Guy , Andrews, Christopher N , Boecxstaens, Veerle , Miwa, Hiroto , Nafteux, Philippe Robert , Sifrim, Daniel , Suzuki, Hidekazu , Tutuian, Radu I. , Zerbib, Frank

Mayo Clinic

Gut | August 2, 2019 | Volume: 68 | Issue: 11 | Pages: 1928-1941

10.1136/gutjnl-2019-318260 | PMID 31375601 Get It

Objective Antireflux surgery can be proposed in patients with GORD, especially when proton pump inhibitor (PPI) use leads to incomplete symptom improvement. However, to date, international consensus guidelines on the clinical criteria and additional technical examinations used in patient selection for antireflux surgery are lacking. We aimed at generating key recommendations in the selection of patients for antireflux surgery. Design We included 35 international experts (gastroenterologists, surgeons and physiologists) in a Delphi process and developed 37 statements that were revised by the Consensus Group, to start the Delphi process. Three voting rounds followed where each statement was presented with the evidence summary. The panel indicated the degree of agreement for the statement. When 80% of the Consensus Group agreed (A+/A) with a statement, this was defined as consensus. All votes were mutually anonymous. Results Patients with heartburn with a satisfactory response to PPIs, patients with a hiatal hernia (HH), patients with oesophagitis Los Angeles (LA) grade B or higher and patients with Barrett’s oesophagus are good candidates for antireflux surgery. An endoscopy prior to antireflux surgery is mandatory and a barium swallow should be performed in patients with suspicion of a HH or short oesophagus. Oesophageal manometry is mandatory to rule out major motility disorders. Finally, oesophageal pH (±impedance) monitoring of PPI is mandatory to select patients for antireflux surgery, if endoscopy is negative for unequivocal reflux oesophagitis. Conclusion With the ICARUS guidelines, we generated key recommendations for selection of patients for antireflux surgery.
Field Test Results of Sex- and Gender-Specific Health Multimedia Case-Based Learning Modules
Casanova, Robert, Miller, Virginia M. , Cheon, Jongpil , Barron, Rebecca , Cannaday, Rania, Case, Gretchen A. , Digre, Kathleen B. , Jensen, Jani R., McGregor, Alyson J. , Pippitt, Karly , Davidge‐Pitts, Caroline , Pomeroy, Brian, Webster, Dan, Jenkins, Marjorie , Jensen, Jani, Davidge-Pitts, Caroline, Gilmore, Linda

Mayo Clinic

Journal of Women's Health | August 2, 2019 | Volume: 28 | Issue: 12 | Pages: 1755-1761

10.1089/jwh.2018.7504 | PMID 31373877 Get It

Background: The sex- and gender-specific health (SGSH) multimedia case-based learning modules (MCBLMs) were developed to address the absence of validated or peer-reviewed material that incorporates topics of sex and gender differences into medical curricula. This article provides the methodology for development of the modules and reports the results of a field test of the modules in different medical educational settings. Methods: MCBLMs were created by a multidisciplinary committee of scientists, health profession educators, and students. Two modules, osteoporosis and diabetes, were tested in various settings based on the curricular needs at each of the five accredited institutions. Each module consisted of a pretest and three interactive, multimedia stand-alone sections with post-tests. Scores on the tests were compared using a paired-samples t -test. A postmodule survey was used to evaluate the format. Results: Four hundred eighteen students participated in the field testing. For the 194 who completed the osteoporosis module, the post-test scores (M = 13.71, standard deviation [SD] = 2.09) were significantly higher than the pretest scores (M = 10.54, SD = 2.41), p < 0.001. Post-test scores for the 285 who completed the diabetes module (M = 16.55, SD = 2.46) were also significantly higher than the pretest scores (M = 13.71, SD = 2.09), p < 0.001. The postmodule survey showed positive acceptance of the format with an average score of 3.54/4 for osteoporosis and 3.45/4 for diabetes. Conclusion: The SGSH MCBLM field testing results show that the modules have a positive effect on content knowledge in multiple settings and are well accepted by learners.
Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016
Jeffery, Molly M. , Hooten, W. Michael , Jena, Anupam B. , Ross, Joseph S. , Shah, Nilay D. , Karaca‐Mandic, Pinar , Jeffery, Molly Moore , Ross, Joseph S

Mayo Clinic

JAMA Network Open | August 2, 2019 | Volume: 2 | Issue: 8 | Pages: e198325

10.1001/jamanetworkopen.2019.8325 | PMID 31373650 Get It

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective
Bridoux, Frank , Javaugue, Vincent , Nasr, Samih H. , Leung, Nelson

Mayo Clinic

Nephrology Dialysis Transplantation | August 2, 2019 | Volume: 36 | Issue: 2 | Pages: 208-215

10.1093/ndt/gfz176 | PMID 33494099 Get It

Abstract Proliferative glomerulonephritis (GN) with monoclonal immunoglobulin deposits (PGNMIDs) is a recently described entity among the spectrum of monoclonal gammopathy of renal significance (MGRS). The disease is renal limited and manifests with chronic glomerular disease, altered renal function and albuminuria, sometimes in the nephrotic range. Acute nephritic syndrome is rare. PGNMID occurs mostly in the sixth decade, but it may affect young adults. Histologically, PGNMID is characterized predominantly by membranoproliferative GN and less frequently by diffuse endocapillary GN, mesangioproliferative GN or atypical membranous GN. Immunofluorescence and electron microscopic studies are the cornerstone of diagnosis, showing granular deposits involving glomeruli only, and composed of monotypic immunoglobulin G (IgG), with a single heavy chain subclass (most commonly IgG3) and light chain (LC) restriction (usually κ), admixed with complement deposits. PGNMID variants with monotypic LC-only, IgA or IgM deposits are uncommon. Ultrastructurally, deposits are amorphous with predominant subendothelial and mesangial distribution. PGNMID should be distinguished from type 1 cryoglobulinemic GN and immunotactoid GN, which share some common pathological features. Contrary to other MGRS lesions, the rate of detection of the nephrotoxic monoclonal Ig in the serum or urine, and of an abnormal bone marrow B-cell clone, is only ∼30%. Renal prognosis is poor, with progression to end-stage renal disease in 25% of patients within 30 months and frequent early recurrence on the renal allograft. The pathophysiology of PGNMID is unclear and its treatment remains challenging. However, recent studies indicate that clone-targeted chemotherapy may significantly improve renal outcomes, opening future perspectives for the management of this rare disease.
Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy
Yamada, Satsuki , Arrell, D. Kent , Rosenow, Christian S. , Behfar, Atta , Behfar, Atta , Bartúnek, Jozef , Terzic, André

Mayo Clinic

Stem Cells Translational Medicine | August 2, 2019 | Volume: 9 | Issue: 1 | Pages: 74-79

10.1002/sctm.19-0149 | PMID 31373782 Get It

Abstract Response to stem cell therapy in heart failure is heterogeneous, warranting a better understanding of outcome predictors. This study assessed left ventricular volume, a surrogate of disease severity, on cell therapy benefit. Small to large infarctions were induced in murine hearts to model moderate, advanced, and end-stage ischemic cardiomyopathy. At 1 month postinfarction, cardiomyopathic cohorts with comparable left ventricular enlargement and dysfunction were randomized 1:1 to those that either received sham treatment or epicardial delivery of cardiopoietic stem cells (CP). Progressive dilation and pump failure consistently developed in sham. In comparison, CP treatment produced significant benefit at 1 month post-therapy, albeit with an efficacy impacted by cardiomyopathic stage. Advanced ischemic cardiomyopathy was the most responsive to CP-mediated salvage, exhibiting both structural and functional restitution, with proteome deconvolution substantiating that cell therapy reversed infarction-induced remodeling of functional pathways. Moderate cardiomyopathy was less responsive to CP therapy, improving contractility but without reversing preexistent heart enlargement. In end-stage disease, CP therapy showed the least benefit. This proof-of-concept study thus demonstrates an optimal window, or “Goldilocks principle,” of left ventricular enlargement for maximized stem cell-based cardiac repair. Disease severity grading, prior to cell therapy, should be considered to inform regenerative medicine interventions. Significance statement This article documents that cardiac chamber enlargement postinfarction is a predictor of cardiopoietic stem cell therapy response. Left ventricular size pretherapy could thus serve to guide the selection of ischemic heart failure candidates most suitable to receive a regenerative intervention.
Patient With Nonalcoholic Steatohepatitis Posttransplant Develops Acute Hepatitis B Virus Causing Graft Failure
Chaney, Amanda , Chaney, Amanda J

Mayo Clinic

Clinical Liver Disease | August 2, 2019 | Volume: 14 | Issue: 1 | Pages: 8-11

10.1002/cld.785 | PMID 31391929 Get It

Cortical surface intracranial electrodes identify clinically relevant seizures missed on scalp EEG after traumatic intracranial hemorrhage
Marcellino, Chris , Lapalme‐Remis, Samuel , Payne, Eric T. , Hocker, Sara E. , Hocker, Sara, Marcellino, Christopher , Rabinstein, Alejandro A. , Gompel, Jamie J. Van , Worrell, Gregory A.

Mayo Clinic

Epileptic Disorders | August 2, 2019 | Volume: 20 | Issue: 6 | Pages: 551-556

10.1684/epd.2018.1015 | PMID 30530419 Get It

ABSTRACTSeizures and other electrophysiological disturbances are an under‐recognized cause of coma, focal deficits, and prolonged encephalopathy following subdural hematoma evacuation. In these patients, it is possible that seizures remain unrecognized on scalp EEG. It has been shown that a high burden of seizures and other electrophysiological disturbances exist following surgical evacuation and underlie the encephalopathy commonly seen in this patient population, predisposing them to medical complications and confounding estimates of prognosis. As part of a research protocol, we are performing intraoperative placement of cortical surface (non‐parenchyma penetrating) intracranial EEG on patients who present after trauma and require emergent decompressive hemicraniectomy.In this case report of a patient with high‐velocity traumatic epidural, subdural, and subarachnoid hemorrhages, we identified frequent non‐convulsive seizures or seizure‐like SIRPIDs with intracranial cortical surface monitoring that were not identified on simultaneous scalp EEG. Stimulation consistently triggered these electrographic seizures in addition to rhythmic lateralized periodic discharges. His mental status improved rapidly after resolution of these electrographic seizures shortly after increasing antiseizure medications, suggesting that they may have been contributing to his encephalopathy. More research is needed to determine the frequency of this phenomenon and determine whether treatment of such seizures improves patient outcomes.
GAD65 antibody‐associated autoimmune epilepsy with unique independent bitemporal‐onset ictal asystole
D’Souza, Caitlin E. , Feyissa, Anteneh M. , Feyissa, A M

Mayo Clinic

Epileptic Disorders | August 2, 2019 | Volume: 20 | Issue: 3 | Pages: 204-208

10.1684/epd.2018.0971 | PMID 29905150 Get It

ABSTRACTAntibodies against the 65‐kDa isoform of the intracellular enzyme, glutamate decarboxylase (GAD65), have been found in patients with limbic encephalitis and drug‐resistant autoimmune epilepsy. We report a 22‐year‐old female who presented with new‐onset seizures and neuropsychiatric symptoms. Video‐EEG captured unique, independent bitemporal‐onset focal seizures with impaired awareness and ictal asystole. An autoimmune epilepsy panel revealed elevated GAD65 antibodies in the serum (225 nmol/l) and CSF (2.78 nmol/l), while [18F]‐fluoro‐deoxy‐glucose positron emission tomography showed bitemporal hypometabolism (left > right). The patient was diagnosed with GAD65 antibody‐associated autoimmune epilepsy. Our observation adds to the spectrum of neurocardiac syndromes associated with autoimmune epilepsy.
The role of EEG in the diagnosis and classification of the epilepsy syndromes: a tool for clinical practice by the ILAE Neurophysiology Task Force (Part 2)
Koutroumanidis, Michalis , Arzimanoglou, Alexis , Caraballo, Roberto , Goyal, Sushma, Kamińska, Anna , Laoprasert, Pramote, Oguni, Hirokazu , Tatum, William O. , Thomas, Pierre , Trinka, Eugen , Vignatelli, Luca , Moshé, Solomon L. , Vignatelli, Luca , Moshé, Solomon L , Trinka, Eugen , Rubboli, Guido

Mayo Clinic

Epileptic Disorders | August 2, 2019 | Volume: 19 | Issue: 4 | Pages: 385-437

10.1684/epd.2017.0952 | PMID 29350182 Get It

ABSTRACTThe concept of epilepsy syndromes, introduced in 1989, was defined as “clusters of signs and symptoms customarily occurring together”. Definition of epilepsy syndromes based on electro‐clinical features facilitated clinical practice and, whenever possible, clinical research in homogeneous groups of patients with epilepsies. Progress in the fields of neuroimaging and genetics made it rapidly clear that, although crucial, the electro‐clinical description of epilepsy syndromes was not sufficient to allow much needed development of targeted therapies and a better understanding of the underlying pathophysiological mechanisms of seizures. The 2017 ILAE position paper on Classification of the Epilepsies recognized that “as a critical tool for the practicing clinician, epilepsy classification must be relevant and dynamic to changes in thinking”. The concept of “epilepsy syndromes” evolved, incorporating issues related to aetiologies and comorbidities. A comprehensive update (and revision where necessary) of the EEG diagnostic criteria in the light of the 2017 revised terminology and concepts was deemed necessary. Part 2 covers the neonatal and paediatric syndromes in accordance with the age of onset. [Published with educational EEG plates atwww.epilepticdisorders.com].